Journal of Vaccines & Clinical Trials

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

New Ways to Design Vaccines: Nanodelivery, Cancer Vaccines and Systems Biology

Nanomaterials with defined physico-biochemical properties are versatile drug delivery platforms that may address the key technical challenges facing cancer vaccines and immunotherapy. They are typically made from natural or synthetic materials. Nanoparticles could enable a targeted delivery of tumor antigens and therapeutics and amplify immune activation via the use of new stimuli-responsive or immunostimulatory materials. I will point out here and briefly review the current state-of-the-art in nanoparticle-based strategies designed to potentiate cancer immunotherapies, including cancer vaccines with subunit antigens (e.g., oncoproteins, DNA and mRNA antigens) and whole-cell tumor antigens, dendritic cell-based vaccines, and immunotherapeutics based on cell death immune checkpoint blockade.

Special Features

Full Text

View

Track Your Manuscript

Share This Page

Media Partners

Associations